Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...
The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...
2don MSN
Reducing inflammation may protect against early age-related macular degeneration-like vision loss
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
News-Medical.Net on MSN
Inflammation control can protect against AMD-like retinal damage
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...
Coave Therapeutics has announced its lead gene therapy program, CoTx-101, for the treatment of retinal vascular diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback